Correction: Invitrogen Suit Against GE Healthcare Transferred to Texas
March 16, 2009
Correction: Invitrogen Suit Against GE Healthcare Transferred to Texas
The suit alleges infringement of patents covering reverse transcriptase technology, and is in addition to a suit Invitrogen filed against GE last year for alleged infringement.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- IP Watch: Mayo Clinic, GE, Life Tech, TriLink, Penn State, Exact Sciences Win US Patents
January 30, 2013 / PCR Insider - IP Watch: Recent Patents Related to PCR, Nucleic Acid Amplification, and Sample Prep
August 10, 2011 / PCR Insider - IP Update: Recent Patents Related to PCR, Nucleic Acid Amplification, and Sample Prep
June 3, 2010 / PCR Insider - Life Tech's 3500 Sanger Sequencers Receive Regulatory Approval in Canada
May 20, 2013 / GenomeWeb Daily News - Researchers Report on Mutational Patterns in Adenoid Cystic Carcinoma
May 20, 2013 / GenomeWeb Daily News